Patient-Focussed Drug Development
CFRI’S EXTERNALLY-LED PATIENT-FOCUSED DRUG DEVELOPMENT (PFDD) MEETING ON CYSTIC FIBROSIS

Monday, October 29, 2018 • 8:30 am - 3:30 pm EST
College Park Marriott Hotel and Conference Center 
Hyattsville, Maryland

CFRI’s PFDD meeting on cystic fibrosis (CF) will integrate the patient voice into the drug development and review process during a one-day, live-streamed, interactive meeting of individuals with CF, parents/caregivers of those with CF, CF clinicians, and FDA representatives, during which the patient voice and perspective will be shared and expanded upon in relation to the disease, current and future therapies.


The Externally-Led Patient-Focused Drug Development Meeting on Cystic Fibrosis provides the opportunity to collaboratively incorporate the experience of people with CF during benefit-risk decisions, and to constructively expand communication between the FDA and the CF patient community.


COST: Free. Attendees must register to either attend in person, or attend via live streaming. Those participating online will have the opportunity to provide input.

For a PDF of the agenda, click here.

Continental breakfast and a boxed lunch will be provided to those attending in person.


CROSS-INFECTION CONTROL POLICY:
Due to cross-infection risks, individuals with cystic fibrosis are asked to participate online.

SPONSORSHIPS AVAILABLE: Sponsorship levels range from $2,500 – $27,500. Contact Tony Adessa for more information at tadessa@cfri.org.

For any questions, please call us at 650-665-7559, or email cfri@cfri.org.





Register Early!


www.cfri.org